Premium
Adjunctive antipsychotic after mania remission effective over 24 weeks
Publication year - 2016
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30125
Subject(s) - mania , risperidone , olanzapine , medicine , adjunctive treatment , antipsychotic , adverse effect , mood , schizophrenia (object oriented programming) , bipolar disorder , psychiatry
Twenty‐four weeks of adjunctive therapy with risperidone or olanzapine after remission of acute mania was effective in reducing relapse to a mood episode, but a longer 52‐week duration of adjunctive antipsychotic treatment showed no additional benefit and increased the risk of adverse effects, a new study has found.